SCHEMBL10107050

SCHEMBL10107050

CCOC(=O)C=C1CCC(C(O)c2ccc(OC)c(OC(C)C)c2)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.44
PDE4B Q07343 5/20 0.39
PDE4D Q08499 3/20 0.39
PDE4A P27815 2/20 0.39
PDE4C Q08493 2/20 0.39
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 5/20 0.38
CTDSP1 Q9GZU7 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ACHE P22303 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10102167 0.90 ESR2 (0.46) ESR2ALDH1A1ACHEL3MBTL1
SCHEMBL10106836 0.85 ESR2 (0.41) ESR2PDE4BALDH1A1MAPTMAPK1
SCHEMBL14042199 0.80 HIF1A (0.46) PDE4BPDE4DPDE4APDE4CHIF1A
SCHEMBL661555 0.79 PDE4B (0.45) PDE4BPDE4DPDE4APDE4CALDH1A1
SCHEMBL10102170 0.77 ESR2 (0.41) ESR2CTDSP1ACHEL3MBTL1
SCHEMBL661285 0.76 PDE4D (0.46) PDE4BPDE4DPDE4APDE4CHIF1A
SCHEMBL662935 0.70 CYP3A4 (0.49) PDE4BPDE4DPDE4APDE4CALDH1A1
SCHEMBL4813818 0.69 FDPS (0.69) PDE4BPDE4DPDE4APDE4CALDH1A1
SCHEMBL4813804 0.69 FDPS (0.69) PDE4BPDE4DPDE4APDE4CALDH1A1
SCHEMBL658699 0.68 PDE4D (0.43) PDE4BPDE4DPDE4APDE4CALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8536157-B2 Non-steroidal compounds THE UNIVERSITY OF MELBOURNE (AU) 2013-09-17 US disclosed
US-20120046255-A1 NON-STEROIDAL COMPOUNDS THE UNIVERSITY OF MELBOURNE of ROYAL PARADE PARKVILLE (AU) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046255-A1 NON-STEROIDAL COMPOUNDS PTGES2, PTGES, PTGES3 ESR2 75/4885PDE4B 823/4885PDE4D 1364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.